Cystic Fibrosis
📧 Sign up to get email alerts when something new happens for Cystic Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: A Study to Evaluate the Relative Bioavailability and Food Effect of a VX-118 Tablet Formulation [Phase 1]
Phase 1 study evaluating the relative bioavailability and food effect of VX-118 tablet formulation has been completed in cystic fibrosis.
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: RATNO, Reducing Antibiotic Tolerance Using Nitric Oxide in CF - a Phase 2 Pilot Study [Phase 2]
An update on a Phase 2 pilot trial (RATNO) investigating nitric oxide to reduce antibiotic tolerance in cystic fibrosis.
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: Gut Imaging for Function & Transit in CF - GIFT-CF 3
A completed clinical trial evaluating gut imaging for function and transit in cystic fibrosis (GIFT-CF 3).
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients [Phase 3]
A Phase 3 trial comparing Aeroquin to Tobramycin Inhalation Solution in cystic fibrosis patients has completed, with results posted in May 2…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: A Study of Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ/TEZ/D-IVA) in Healthy Adult Panelists [Phase 1]
Phase 1 trial in healthy adult panelists evaluating the safety of the VNZ/TEZ/D-IVA fixed-dose combination has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis
This clinical trial update shows a recruiting study sponsored by Ospedale San Raffaele to identify new biological markers for progression of…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
This clinical trial update describes a study on viral infections and the airway microbiome in young children with cystic fibrosis; the curre…
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: Study of a Nebulised Nitric Oxide Generating Solution in Patients With Mycobacterium Abscessus [Phase 2]
A Phase 2 trial evaluating a nebulised nitric oxide generating solution in cystic fibrosis patients with Mycobacterium abscessus has been te…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy [Phase 3]
Phase 3 trial update reporting long-term safety and efficacy results for VX-445 combination therapy in cystic fibrosis; results have been po…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: A Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis (CF) Particpants 6 Years and Older and F/MF Genotypes [Phase 3]
This Phase 3 long-term safety and efficacy study of the elexacaftor/tezacaftor/ivacaftor combination in cystic fibrosis patients aged 6 year…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Airway Microbiome of Cystic Fibrosis Patients [NA]
A clinical trial is studying the airway microbiome in patients with cystic fibrosis, with the study currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Effects of SIMEOX on Airway Clearance in Cystic Fibrosis [NA]
A completed clinical trial evaluating the effects of SIMEOX on airway clearance in patients with cystic fibrosis.
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Characterization of Antibacterial Antibodies in Patients With Cystic Fibrosis
This clinical trial update describes a study characterizing antibacterial antibodies in patients with cystic fibrosis, currently recruiting …
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER) [Phase 4]
Phase 4 real-world study evaluating outcomes of novel modulator therapy combinations in people with cystic fibrosis, including those with cy…
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: French Validation of the AdT-Physio Scale
This clinical trial update reports the French validation of the AdT-Physio Scale for cystic fibrosis. The study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: HERO-2: Home-Reported Outcomes With CFTR Modulator Therapy
The HERO-2 trial update reports home-reported outcomes from participants receiving CFTR modulator therapy for cystic fibrosis, and the study…
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: Improving the Well-being of Caregivers of Cystic Fibrosis Patients During Physiotherapy Treatment
This clinical trial is currently recruiting to study interventions aimed at improving the well-being of caregivers of cystic fibrosis patien…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: The Use of Novel Diagnostic Tools to Increase Detection of Early Fibrosis in Cystic Fibrosis Related Liver Disease to Improve Clinical Management
A completed clinical trial evaluating novel diagnostic tools to improve detection of early fibrosis in cystic fibrosis-related liver disease…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI) [Phase 2]
Phase 2 trial evaluating the effect of proton pump inhibitors on fat absorption in cystic fibrosis with pancreatic exocrine insufficiency. T…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis [Phase 3]
Phase 3 trial results for MP-376 (Aeroquin), an inhaled levofloxacin, in patients with cystic fibrosis have been posted.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: The Effect of Telerehabilitation on Functional Capacity, Oxidative Stress and Respiratory Parameters in Cystic Fibrosis [NA]
A completed clinical trial from Hacettepe University evaluating whether telerehabilitation improves functional capacity, oxidative stress, a…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Saline Hypertonic in Preschoolers + CT [Phase 2, Phase 3]
Phase 2/3 clinical trial update for saline hypertonic treatment in preschoolers with Cystic Fibrosis; study completed.
-
FDA approval · 2024-02-28FDA Approved: PERTZYE — Supplemental Application (Digestive Care, Inc.)
FDA approved a supplemental application for PERTZYE (pancrelipase) submitted by Digestive Care, Inc.
-
FDA approval · 2024-02-28FDA Approved: PANCREAZE — Supplemental Application (VIVUS LLC)
FDA approved a supplemental application for PANCREAZE, a pancreatic enzyme replacement product, submitted by VIVUS LLC.
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: Pharmacokinetics of Omadacycline in Cystic Fibrosis [Phase 4]
A Phase 4 clinical trial reports pharmacokinetics data for omadacycline in patients with cystic fibrosis.